Washington [US], December 4 (ANI): A new study has found that a novel T cell genetically engineered by University of Arizona Health Sciences researchers is able to target and attack pathogenic T cells that cause Type 1 diabetes, which could lead to new immunotherapy treatments.
Boston (Massachusetts) [US], November 29 (ANI): A new study led by researchers from Beth Israel Deaconess Medical Center (BIDMC) sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.
Washington [US], November 28 (ANI): Children having African ancestry are more prone to developing obesity if they possess a genetic variant that reduces their ability to produce the hormone leptin.
Washington [US], November 28 (ANI): A recent study has found that young children of African ancestry are more at risk of developing obesity if they possess a genetic variant that reduces their ability to produce the hormone leptin.
New Delhi [India], November 27 (ANI): Asserting "genetic" similarities, India on Friday assured Nepal that meeting its requirements for the COVID-19 vaccine would be a priority, once a candidate is finalised and rolled out.
Boston (Massachusetts) [US], November 26 (ANI): With Coronavirus being the most experimented field from past few months', a new study led by Beth Israel Deaconess Medical Center (BIDMC) sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.
Washington [US], November 23 (ANI): Young children of African ancestry are more at risk of developing obesity if they possess a genetic variant that reduces their ability to produce the hormone leptin.
Dallas [US], November 21 (ANI): While maintaining a good sleeping pattern helps in concentration in tasks, a recent study has pointed out on the additional benefit of a good sleep pattern. It suggests that the adults with the healthiest sleep patterns had a 42 per cent lower risk of heart fa
Washington [US], November 21 (ANI): According to a study published in JAMA Network Open, the population-wide screening for genetic variants linked to hereditary breast and ovarian cancer may be cost-effective in women between the ages of 20 and 35.
Washington [US], November 16 (ANI): Population-wide screening for genetic variants linked to hereditary breast and ovarian cancer may be cost-effective in women between the ages of 20 and 35, according to a study.